Foley & Lardner LLP recently issued the following announcement.
LOCATION:
AC Hotel San Francisco Airport/Oyster Point Waterfront
1333 Veterans Boulevard
South San Francisco, CA 94080
AGENDA:
Registration and Breakfast
8:15 a.m. – 9:00 a.m. PT
Conference Program:
9:00 a.m. – 2:45 p.m. PT
Reception:
2:45 p.m. – 4:00 p.m. PT
How are businesses across the health care and life sciences spectrum collaborating to capitalize on the commercial promise of personalized medicine? Join us at the Business of Personalized Medicine Summit at Oyster Point on Thursday, February 27, 2020, to find out!
Since the completion of the Human Genome Project in 2003, the genomic revolution has spurred immeasurable excitement and support surrounding the promise of personalized medicine, setting high expectations for a new era of health care and rapidly transforming the field into a multi-billion dollar industry.
While realizing the medical and commercial potential of personalized medicine has turned out to be neither quick nor easy, we could finally be on the cusp of widespread clinical adoption and improved patient outcomes thanks to recent scientific and technological advances, including with CRISPR gene editing and targeted therapies. In fact, in its latest report, Cancer Statistics, 2020, the American Cancer Society cites a 2.2% drop in the U.S. cancer death rate from 2016 to 2017 — the largest single-year drop ever recorded — and attributes it largely to the development of targeted therapies and other personalized medicines for the treatment of lung and skin cancers.
Original source can be found here.